Jenna C. Carpenter

460 total citations
8 papers, 306 citations indexed

About

Jenna C. Carpenter is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Jenna C. Carpenter has authored 8 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Genetics. Recurrent topics in Jenna C. Carpenter's work include Neuroscience and Neuropharmacology Research (4 papers), CRISPR and Genetic Engineering (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Jenna C. Carpenter is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), CRISPR and Genetic Engineering (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Jenna C. Carpenter collaborates with scholars based in United Kingdom, Italy and India. Jenna C. Carpenter's co-authors include Gabriele Lignani, Stéphanie Schorge, Dimitri M. Kullmann, Claudia Di Berardino, Silvia Marenna, Serena Giannelli, Simone Bido, Vania Broccoli, Gaia Colasante and Giuseppe Morabito and has published in prestigious journals such as Science, Brain and Science Advances.

In The Last Decade

Jenna C. Carpenter

8 papers receiving 306 citations

Peers

Jenna C. Carpenter
Susanne Ruf Germany
Jonathan Cornford United Kingdom
Margaret Maronski United States
Maéva Langouët United States
Melinda S. Martin United States
Jenna C. Carpenter
Citations per year, relative to Jenna C. Carpenter Jenna C. Carpenter (= 1×) peers Simone Brusco

Countries citing papers authored by Jenna C. Carpenter

Since Specialization
Citations

This map shows the geographic impact of Jenna C. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenna C. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenna C. Carpenter more than expected).

Fields of papers citing papers by Jenna C. Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenna C. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenna C. Carpenter. The network helps show where Jenna C. Carpenter may publish in the future.

Co-authorship network of co-authors of Jenna C. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Jenna C. Carpenter. A scholar is included among the top collaborators of Jenna C. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenna C. Carpenter. Jenna C. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Carpenter, Jenna C., et al.. (2024). Early developmental alterations of CA1 pyramidal cells in Dravet syndrome. Neurobiology of Disease. 201. 106688–106688. 2 indexed citations
2.
Carpenter, Jenna C., Marco Leite, Stéphanie Schorge, et al.. (2023). Anti-seizure gene therapy for focal cortical dysplasia. Brain. 147(2). 542–553. 21 indexed citations
3.
Carpenter, Jenna C., Marco Leite, Albert Snowball, et al.. (2022). On-demand cell-autonomous gene therapy for brain circuit disorders. Science. 378(6619). 523–532. 55 indexed citations
4.
Carpenter, Jenna C. & Gabriele Lignani. (2021). Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?. Neurotherapeutics. 18(3). 1515–1523. 17 indexed citations
5.
Carpenter, Jenna C., et al.. (2021). Progressive myoclonus epilepsyKCNC1variant causes a developmental dendritopathy. Epilepsia. 62(5). 1256–1267. 13 indexed citations
6.
Kaserer, Teresa, Angela Wu, Alexandre Mouravlev, et al.. (2019). Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics. Science Advances. 5(4). eaaw1567–eaaw1567. 47 indexed citations
7.
Colasante, Gaia, Gabriele Lignani, Simone Brusco, et al.. (2019). dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice. Molecular Therapy. 28(1). 235–253. 149 indexed citations
8.
Carpenter, Jenna C. & Stéphanie Schorge. (2018). The voltage-gated channelopathies as a paradigm for studying epilepsy-causing genes. Current Opinion in Physiology. 2. 71–76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026